In focus
Latest feed
A Glimmer of Hope: New Alzheimer's Drug Shows Remarkable Safety in Early Trial
The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare
India’s Experts Call for an Overhaul of GM & Genome‑Edited Crop Regulations
Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws
